Mutational analysis of SARS-CoV-2 ORF8 during six months of COVID-19 pandemic

SARS-CoV-2, the causal agent of COVID 19, is a new human pathogen that appeared in Wuhan, late December 2019. SARS-CoV-2 is a positive sense RNA virus, having four structural and six accessory proteins including that encoded by ORF8 gene known to be one of the most hypervariable and rapidly evolving genes. Thus, global characterization of mutations in this gene is important for pathogenicity and diagnostics. 240 different nonsynonymous mutations and 2 deletions were identified in 45,400 ORF8 nucleotide sequences during six months pandemic with about half of these variants were deleterious for ORF8, and the quarter of them were located in conserved amino acids. Genetic diversity analysis showed two main regions that harbor L84S and S24L. L84S is by far the most predominant mutation, followed by S24L that appeared first in USA. Phylogenetic analysis of ORF8 variants revealed the appearance of small clades with that of L84S being closer to bats. This is the first study that revealed the global nonsynonymous mutations in ORF8 from January to June 2020. •SARS-CoV-2, the causal agent of COVID 19, is still infecting people.•As the virus is propagating mutations in its genome occurs.•Global characterization of mutations, especially in fast evolving genes like ORF8 is very important for pathogenicity and diagnostics.•240 different mutations were identified as well as their effects were predicted.•Genetic diversity analysis showed two main regions, that harbor L84S and S24L.•This is the first study that revealed the global nonsynonymous mutations in ORF8 from January to June, 2020.